4-(5-methyl-6H-benzo[b][1,4]benzoxazepin-6-yl)-N-oxidanyl-benzamide
|
|
Descriptors Computed from Structure
Canonical SMILES:
CN1C(C2=CC=CC=C2OC3=CC=CC=C31)C4=CC=C(C=C4)C(=O)NO
Isomeric SMILES
CN1C(C2=CC=CC=C2OC3=CC=CC=C31)C4=CC=C(C=C4)C(=O)NO
InChI
InChI=1S/C21H18N2O3/c1-23-17-7-3-5-9-19(17)26-18-8-4-2-6-16(18)20(23)14-10-12-15(13-11-14)21(24)22-25/h2-13,20,25H,1H3,(H,22,24)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (phenylmethyl) N-[(5S)-6-oxidanylidene-5-[(4R)-3-oxidanylidene-4-(2-phenylethanoylamino)-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]-6-[[(1S)-1-phenylethyl]amino]hexyl]carbamate
- 4-(3-chloranyl-5H-benzo[b][1,4]benzodiazepin-6-yl)-N-oxidanyl-benzamide
- N-oxidanyl-4-pyrido[2,3-b][1,5]benzoxazepin-5-yl-benzamide
- (2S)-6-azanyl-2-[(4R)-3-oxidanylidene-4-(2-phenylethanoylamino)-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]-N-phenethyl-hexanamide; 2,2,2-tris(fluoranyl)ethanoic acid
- 4-(8-fluoranylbenzo[b][1,4]benzoxazepin-6-yl)-N-oxidanyl-benzamide
- (2S)-6-azanyl-2-[(4R)-3-oxidanylidene-4-(2-phenylethanoylamino)-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]-N-phenethyl-hexanamide
- 4-(8-methoxybenzo[b][1,4]benzoxazepin-6-yl)-N-oxidanyl-benzamide
- (2S)-6-azanyl-N-(naphthalen-1-ylmethyl)-2-[(4R)-3-oxidanylidene-4-(2-phenylethanoylamino)-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]hexanamide; 2,2,2-tris(fluoranyl)ethanoic acid
- (1S,3S)-3-[2-[methyl(propanoyl)amino]propan-2-yl]-N-[(3R)-3-oxidanyl-1-phenyl-4-[(3-propan-2-ylphenyl)methylamino]butan-2-yl]cyclohexane-1-carboxamide
- (2S)-6-azanyl-N-(naphthalen-1-ylmethyl)-2-[(4R)-3-oxidanylidene-4-(2-phenylethanoylamino)-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]hexanamide
